NASDAQ Watch List: ARCA Biopharma, Inc. (NASDAQ:ABIO) and Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) Added to Growing Stock Report's NASDAQ Watch List.

New York, NY -- (SBWIRE) -- 03/05/2013 -- Growing Stock Report expands its NASDAQ Watch List adding ARCA biopharma, Inc. (NASDAQ:ABIO) and Acura Pharmaceuticals, Inc. (NASDAQ:ACUR)

ARCA biopharma, Inc. (NASDAQ:ABIO) a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced a 6-for-1 reverse split of its common stock. The reverse stock split became effective on March 4, 2013 at 5:01 p.m. Eastern Time, and ARCA’s common stock will continue trading on The NASDAQ Capital Market, on a split-adjusted basis. This breaking news has prompted Growing Stock Report to add ARCA biopharma, Inc. (NASDAQ:ABIO) to their NASDAQ Watch List.

Click Here to find out what other Investors are saying about ARCA biopharma, Inc. (NASDAQ:ABIO)

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) a specialty pharmaceutical company that engages in the research, development, and commercialization of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies announced today that its new next generation pseudoephedrine with abuse deterrent technology will now be stocked by chain drug store KERR DRUG. This recent news has prompted Growing Stock Report to add Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) to their NASDAQ Watch List.

Click Here to find out what other Investors are saying about Acura Pharmaceuticals, Inc. (NASDAQ:ACUR)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com